Sign In
Buy ALT
$2.92
+0.0500 (+1.74%)
At Close: Jun 04, 2026
ALT5 Sigma Reports a Record Month at Over $240 Million in Transaction Volume
08:30am, Wednesday, 09'th Oct 2024
LAS VEGAS, NV / ACCESSWIRE / October 9, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlemen
Consider Buying Potential Takeover Target Altimmune
02:48pm, Wednesday, 02'nd Oct 2024
Altimmune, Inc.'s weight loss drug, pemvidutide, shows significant superiority in lean mass retention and liver fat reduction, making it a potential takeover target. High short interest in Altimmune s
ALT5 Announces Plan to Separate Into Two Independent Publicly Traded Companies
08:30am, Wednesday, 02'nd Oct 2024
LAS VEGAS, NV / ACCESSWIRE / October 2, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS) ("ALT5" or the "Company"), a fintech innovator providing next-generation blockchain-powered technologies for tokeniz
Altimmune to Participate in the H.C. Wainwright 8th Annual MASH Virtual Conference
07:30am, Tuesday, 01'st Oct 2024
GAITHERSBURG, Md., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that its Chief Executive Officer, Vipin Garg, Ph.D., and
IMPACT trial is evaluating the safety and efficacy of pemvidutide in approximately 190 subjects with MASH; top-line efficacy data expected in Q2 2025
Altimmune: Updated Data Supports Pemvidutide's 'Market Disruptor' Prospects
05:21am, Saturday, 21'st Sep 2024
Pemvidutide shows strong potential in obesity and MASH, preserving lean mass while reducing VAT, which could make it a market leader among GLP-1s. Recent Phase II data reveals pemvidutide's lean loss
Five Top Obesity Stocks to Buy and Hold Long Term
11:50am, Thursday, 12'th Sep 2024
Karl-Hendrik Tittel / Getty Images There's also Altimmune (NASDAQ:ALT), whose pemvidutide treatment led to weight loss while preserving lean mass.
GAITHERSBURG, Md., Sept. 10, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Altimmune, Inc. (Nasdaq:ALT), please note that the reduction of visceral adipose tiss
ALT5 Sigma Reports 104% Year-Over-Year Increase in Transaction Volume to Over US$1.250 Billion for First Eight Months of 2024
11:00am, Tuesday, 10'th Sep 2024
LAS VEGAS, NV / ACCESSWIRE / September 10, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing, settle
Lean Loss Ratio of only 21.9%, representing class-leading preservation of lean mass Maintenance of lean mass preservation in individuals over the age of 60, a population at risk for frailty-related fa
ALT5 Sigma to Exhibit at iFX Bangkok September 16-18, 2024
08:00am, Monday, 09'th Sep 2024
LAS VEGAS, NV / ACCESSWIRE / September 9, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlem
GAITHERSBURG, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that the data from its Phase 2, MRI-based body composit
Altimmune: Emerging Position In Competitive Space, But Risks Remain
11:26am, Tuesday, 27'th Aug 2024
Weight loss drugs like Novo Nordisk's semaglutide and Eli Lilly's tirzepatide dominate the market, with Novo Nordisk leading in sales and Amgen developing a novel competitor. Altimmune's pemvidutide s
ALT5 Sigma Appoints Peter Tassiopoulos as Chief Executive Officer
08:45am, Monday, 26'th Aug 2024
LAS VEGAS, NV / ACCESSWIRE / August 26, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech leader specializing in blockchain-powered technologies for digital asset management, is pleased to announ
ALT 5 Sigma to Exhibit at SiGMA Budapest September 2-4, 2024
11:00am, Friday, 23'rd Aug 2024
LAS VEGAS, NV / ACCESSWIRE / August 23, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlemen
